Phase II Trial of Docetaxal Plus Imatinib Mesylate in the Treatment of Patients With Metastatic Breast Cancer

Autor: Yardley, Denise A., Burris, Howard A., III, Markus, Tiffanie, Spigel, David R., Greco, F. Anthony, Mainwaring, Mark, Waterhouse, David M., Webb, Charles D., Hainsworth, John D.
Zdroj: In Clinical Breast Cancer 2009 9(4):237-242
Databáze: ScienceDirect